{"schema_version":"secwatch.filing_event.v1","accession":"0001091818-26-000140","form_type":"8-K","ticker":"BFNH","cik":"0001310488","company_name":"BIOFORCE NANOSCIENCES HOLDINGS, INC.","filed_at":"2026-09-04T16:51:02+00:00","discovered_at":"2026-09-04T16:52:13.618027+00:00","generated_at":"2026-09-04T16:52:20.322813+00:00","sec_items":["3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BioForce issues 4.5M restricted shares for $2.48M in services","bullets":["On Aug 31, 2026, issued 4,516,909 restricted common shares for services valued at $2,484,300.","Shares sold in private placement under Section 4(2); no commissions or fees paid.","Purchasers represent investment intent; shares carry Rule 144 restrictive legend.","CEO/CFO Richard Kaiser signed filing; company is an emerging growth company."],"urls":{"canonical":"https://secwatch.observer/filing/0001091818-26-000140","json":"https://secwatch.observer/filing/0001091818-26-000140.json","markdown":"https://secwatch.observer/filing/0001091818-26-000140.md","text":"https://secwatch.observer/filing/0001091818-26-000140.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1310488/000109181826000140/0001091818-26-000140-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1310488/000109181826000140/bfnh-09042026_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-04T16:52:20.322813+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}